AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy.

RecruitingNAAges 65 Years - anyAllUniversity of Oslo
💬

In plain words

What the trial is, and whether it could suit you

A poor nutrition status is a modifiable risk factor for cognitive decline and dementia. In particular, evidence links low status of certain B-vitamins and ω-3 fatty acids (ω-3 FA) with a greater risk of cognitive decline and dementia. Although these dietary components are typically investigated separately, post-hoc analyses of existing clinical trial data and experimental work indicate that B-vitamins and ω-3 FA may exert synergistic beneficial effects on processes related to brain health and cognition. However, this combination has not been tested directly in humans. In the proposed BOOMERANG project, we will study the effects of jointly supplementing with B-vitamins and a highly bioavailable ω-3 FA supplement, Lysoveta, on a robust biomarker of brain atrophy, the neurofilament light chain, in a double-blinded randomized controlled trial (RCT) over 3 months in older adults. We will also

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age \> 65 years * A low baseline B-vitamin status as assessed by plasma tHcy \> 11 μmol/L * Normal MMSE score (\>25) Exclusion Criteria: * Unable to give informed consent * Fatty fish intake \> 2 times per week * daily omega-3 supplementation * daily B-vitamin supplementation * history of B12-injections * Serum creatinine \> 90 μmol/L for women and \> 105 μmol/L for men (above reference values) * aspirin use * renal disease * active cancer * Participants can be included if they accept to not take omega-3 supplementation or B-vitamin supplements during the study. They should stop using it and wait 12 weeks before they are invited to a screening visit.
💊

What it tests

  • Intervention
  • Control
📍

Where

1 site
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo
Oslo, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy